Medication Assisted Treatment for Opioid Use Disorders

Medication Assisted Treatment for Opioid Use Disorders

Archived Webinar
Accredited for 1.0 AMA PRA Category 1 Credits
Credit Offering Period:  October 2018 - October 2020

Medication Assisted Treatment for Opioid Use Disorders


Emily Zarse, MD
Addiction Psychiatrist
Area Chief of Addiction Psychiatry
Eskenazi Health Midtown Community Mental Health Center

About the speaker:

Emily Zarse, MD, is an addiction psychiatrist who practices in a dual-diagnosis clinic, treating patients with co-occurring mental illness and substance use disorders. Dr. Zarse co-leads the Opioid Learning Collaborative, which works to improve access to treatment for opioid-dependent patients in primary care as well as to improve provider knowledge on substance use disorders and the use of medication-assisted treatment (MAT). She is a buprenorphine waiver trainer through the American Academy of Addiction Psychiatry and the American Psychiatric Association. Dr. Zarse also collaborates with Eskenazi Health’s emergency department on Project POINT, which aims to improve access to treatment for opiate-overdose patients.

Program description:

Addiction to opioids has reached epidemic proportions in the United States, and communities across the country face increased demands for prevention and substance use services.

Behavioral health organizations increasingly use evidence-based practices such as medication assisted treatment (MAT) to combat the crisis. This “whole patient” approach to the treatment of substanceuse disorders has been found to substantially improve the odds of successful recovery for people who misuse opioids, including heroin and prescription painkillers.

Because of the way opioids affect the brain, behavioral treatments such as therapy and 12-step programs are found to bemore effective when used in combination with medication. Research has shown that this approach can be very effective in helping opioid users stay in recovery for years or even decades.


At the end of this webinarattendees will be able to:

  • Understand MAT’s use of medication in combination with counseling and behavioral therapy.
  • Outline the benefits of MAT.
  • Describe the three primary medications used to treat opioid dependence and addiction.
  • Understand the neurobiology of addiction and how MAT works on neurobiological changes.
  • Identify appropriate duration of treatment.
  • Recognize MAT misconceptions – myths vs. facts.
  • Cite MAT treatment centers in Indiana.

CME Information

Designation Statement: The Indiana State Medical Association (ISMA) designates this enduring internet activity for a maximum of 1.0 AMA PRA Category 1 CreditsTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement: The Indiana State Medical Association (ISMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Note: While offering the CME credit hours listed in these pages, these activities are not intended to provide extensive training in a field.

Disclosure:  In accordance with the ACCME Standards for Commercial Support, educational programs sponsored by the ISMA must demonstrate balance, independence, objectivity and scientific rigor. Prior to the activity, all faculty, authors, editors and planning committee members participating in an ISMA-sponsored activity are required to disclose to attendees any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.  None of the members of the CME Planning Committee or our speaker have any relevant financial relationships to disclose.

Supported by an Educational Grant from: 

If you have questions, you may contact ISMA – Continuing Medical Education staff at (800) 257-4762 or by email at



Once registered, you will receive an immediate “Registration Confirmation” email.  

Within 24 hours, you will receive a secondary email containing a URL link to access the video recording, downloadable PowerPoint slides, pertinent handouts and the program evaluation form.  Please note you must complete the program evaluation in order to finish the course and receive your CME Certificate, which will be sent via email within 2 weeks.  At present, ISMA is processing certificates in batches, based on completion date. 


10/18/2018 - 10/31/2020


Thursday, 18 October 2018

10/18/2018 12:00 PM - 10/31/2020 1:00 PM
10/18/2018 12:00 PM